Markets · 1 sources covering this

What Shah Rukh Khan, Madhuri Dixit and Sachin Tendulkar see in Purple Style Labs IPO? Here’s what DRHP reveals

Shah Rukh Khan, Madhuri Dixit and Sachin Tendulkar are among investors in Purple Style Labs, the parent of Pernia’s Pop-Up Shop, which is gearing up for a ₹660 crore IPO by August-end. The company has received Sebi approval and has expanded from an online platform into physical retail, with 14 Experience Centres across India and London.

Share:WhatsApp X Reddit Facebook

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Economic TimesLean R·1h ago
What Shah Rukh Khan, Madhuri Dixit and Sachin Tendulkar see in Purple Style Labs IPO? Here’s what DRHP reveals
Shah Rukh Khan, Madhuri Dixit and Sachin Tendulkar are among investors in Purple Style Labs, the parent of Pernia’s Pop-Up Shop, which is gearing up for a ₹660 crore IPO by August-end. The company has received Sebi approval and has expanded from an online platform into physical retail, with 14 Experience Centres across India and London.
Read at Economic Times →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/ffe99b7e6d8952a734bed35d6c98789d875229d8"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="What Shah Rukh Khan, Madhuri Dixit and Sachin Tendulkar see in Purple Style Labs IPO? Here’s what DRHP reveals"></iframe>

What Shah Rukh Khan, Madhuri Dixit and Sachin Tendulkar see in Purple Style Labs IPO? Here’s what DRHP reveals

How 1 sources are covering this

What Shah Rukh Khan, Madhuri Dixit and Sachin Tendulkar see in Purple Style Labs IPO? Here’s what DRHP reveals

More from Markets

Geraldine Weiss’s dividend strategy: The blue-chip investing formula that stood the 'Test of Time'

Expert view: Markets navigate hormuz risks, FII comeback and policy crosswinds

Ahead of Market: 10 things that will decide stock market action on Monday

Molbio Diagnostics IPO listing date tomorrow. Here's what GMP, experts signal ahead of debut

Reader

Trust & legal

Across the network